Apolipoprotein E genotyping and phenotyping in type II diabetes mellitus patients with hypertriglyceridemia

Clin Biochem. 1997 Feb;30(1):47-52. doi: 10.1016/s0009-9120(96)00130-0.

Abstract

Objectives: We investigated the possible effect of apolipoprotein E (apo E) polymorphism on hypertriglyceridemia in type II diabetes mellitus (DM) patients by both apo E genotyping and phenotyping methods.

Design and methods: Eighty Korean type II DM patients were evaluated. Restriction isotyping after DNA amplification was used for apo E genotyping. The isoelectric focusing of neuraminidase-treated sera followed by immunoblotting was used for apo E phenotyping.

Results: The concordant rate between apo E genotyping and phenotyping was 96.3%. Apo E genotype frequencies for all 77 concordant cases were as follows: 72.7% for epsilon 3/3; 16.9% for epsilon 3/4; 7.8% for epsilon 2/3; 1.3% for epsilon 2/4, 1.3% for epsilon 4/4; and 0% for epsilon 2/2. There were no significant differences in apo E genotype frequencies between hypertriglyceridemic (n = 42) and normotriglyceridemic (n = 35) groups.

Conclusions: Our findings could not support the association between apo E polymorphism and hypertriglyceridemia among type II DM patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alleles
  • Apolipoproteins E / blood
  • Apolipoproteins E / genetics*
  • Cholesterol / blood
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / genetics*
  • Genotype
  • Humans
  • Hypertriglyceridemia / blood
  • Hypertriglyceridemia / genetics*
  • Middle Aged
  • Phenotype
  • Polymorphism, Genetic / genetics
  • Polymorphism, Genetic / physiology

Substances

  • Apolipoproteins E
  • Cholesterol